Alnylam RNAi Patent Rights means, generally, Patent Rights Controlled by Alnylam that claim (a) Alnylam RNAi Know-How, or (b) the identification, characterization, optimization, construction, expression, formulation, use or production of an Alnylam Royalty Product, as the case may be, and which Alnylam determines in its reasonable judgment to be useful or necessary to Develop, Commercialize and/or Manufacture an Alnylam Royalty Product in the Alnylam Field (including, without limitation, the Alnylam Core Patent Rights and the Alnylam Lipidoid Patent Rights, but specifically excluding Alnylam IOC Technology and any Patent Rights included in Alnylam Collaboration IP or Alnylam’s interest in Joint Collaboration IP).
Alnylam RNAi Patent Rights means Patent Rights that (a) claim (i) Alnylam RNAi Know-How, or (ii) the identification, characterization, optimization, construction, expression, formulation, use or production of an Alnylam Royalty Product, as the case may be, and which Alnylam determines in its reasonable judgment to be useful or necessary to Research, Develop, Commercialize and/or Manufacture an Alnylam Royalty Product in the Alnylam Field in the Territory, and (b) are Controlled by Alnylam at any time during the Collaboration Term or the Manufacturing Term (including, without limitation, the Alnylam Core Patent Rights and the Alnylam Lipidoid Patent Rights, but specifically excluding Alnylam IOC Technology and any Patent Rights included in Alnylam Collaboration IP or Alnylam’s interest in Joint Collaboration IP).
Alnylam RNAi Patent Rights include but are not limited to those which: (i) claim, cover or relate to RNAi Therapeutic Products including but not limited to improvements; or (ii) claim, cover or relate to ALNYLAM Collaboration Inventions; or (iii) are divisions, continuations, any portions of continuations-in-part that are themselves within the definition of ALNYLAM RNAi Patent Rights, reissues, renewals, extensions, supplementary protection certificates, and the like of any covered patents and patent applications and foreign equivalents thereof.
More Definitions of Alnylam RNAi Patent Rights
Alnylam RNAi Patent Rights means any and all patents and patent applications in the Territory (which for the purposes of this Agreement shall be deemed to include certificates of invention and applications for certificates of invention and to exclude Joint Collaboration Patent Rights) which, as of the Effective Date and/or during the Collaboration Term, are Controlled by ALNYLAM or its Affiliates and which are necessary or useful to MERCK in connection with the Technology Collaboration and/or for in vitro and/or in vivo target identification and/or target validation ("ALNYLAM TARGET IDENTIFICATION AND TARGET VALIDATION RNAi PATENT RIGHTS") and/or in the research, development, manufacture, marketing, use, import or sale of RNAi Therapeutic Products within the Therapeutic Collaboration ("ALNYLAM THERAPEUTIC RNAi PATENT RIGHTS"), including, but not limited to, those listed on Schedule 1.8. "ALNYLAM RNAi Patent Rights" include but are not limited to those which: (i) claim, cover or relate to RNAi Therapeutic Products including but not limited to improvements; or (ii) claim, cover or relate to ALNYLAM Collaboration Inventions; or (iii) are divisions, continuations, any portions of continuations-in-part that are themselves within the definition of ALNYLAM RNAi Patent Rights, reissues, renewals, extensions, supplementary protection certificates, and the like of any covered patents and patent applications and foreign equivalents thereof.
Alnylam RNAi Patent Rights means any and all Patent Rights in the Territory (which for the purposes of this Agreement shall be deemed to include certificates of invention and applications for certificates of invention and to exclude Joint Collaboration Patent Rights) which, as of the Original Effective Date and/or during the Collaboration Term, are Controlled by ALNYLAM or its Affiliates and which are necessary or useful to MERCK (a) for in vitro and/or in vivo target identification and/or target validation ("ALNYLAM TARGET IDENTIFICATION AND TARGET VALIDATION RNAI PATENT RIGHTS") and/or (b) in the Development, Manufacture or Commercialization of RNAi Therapeutic Products within the Therapeutic Collaboration, including, but not limited to, those listed on Schedule 1.4. "ALNYLAM RNAi Patent Rights" include but are not limited to those Patent Rights which: (i) claim or Cover RNAi Therapeutic Products including but not limited to improvements; or (ii) claim or cover ALNYLAM Collaboration Inventions; or (iii) are divisions or continuations of ALNYLAM RNAi Patent Rights, or constitute such portions of continuations-in-part as are themselves within the definition of ALNYLAM RNAi Patent Rights.